Samantha S Moe1, Betsy Thomas2, Michael R Kolber3, Christina S Korownyk3, Adrienne J Lindblad4, Nicolas Dugré5, Ricky D Turgeon6, Emélie Braschi7, G Michael Allan8. 1. Clinical Evidence Expert for the College of Family Physicians of Canada (CFPC). smoe@cfpc.ca. 2. Clinical Evidence Expert for the CFPC and Assistant Adjunct Professor in the Department of Family Medicine at the University of Alberta in Edmonton. 3. Professor in the Department of Family Medicine at the University of Alberta. 4. Clinical Evidence Expert Lead for the CFPC and Associate Clinical Professor in the Department of Family Medicine at the University of Alberta. 5. Pharmacist at the CIUSSS du Nord-de-l'Île-de-Montréal and Clinical Associate Professor in the Faculty of Pharmacy at the University of Montreal in Quebec. 6. Assistant Professor at the University of British Columbia and Clinical Pharmacy Specialist at St Paul's Hospital in Vancouver. 7. Hospitalist at the Élisabeth Bruyère Hospital in Ottawa, Ont, and a physician advisor with the CFPC. 8. Director of Programs and Practice Support at the CFPC.
Abstract
OBJECTIVE: To summarize 10 high-quality studies or guidelines from 2021 that have strong relevance to physicians in comprehensive family practice. SELECTING THE EVIDENCE: Routine literature surveillance of abstracts in high-impact journals and EvidenceAlerts was completed by the PEER (Patients, Experience, Evidence, Research) team, a group of health care professionals with a research interest in evidence-based medicine and primary care. Abstracts were screened, selected, and ranked by the PEER team. MAIN MESSAGE: The articles from 2021 that are most likely to impact primary care practice discuss the following topics: empagliflozin for heart failure with preserved ejection fraction; semaglutide for weight loss; stopping antidepressants in primary care; inhaled budesonide for COVID-19; acetylsalicylic acid for preeclampsia prevention; quarter-dose blood pressure medications for hypertension; aggressive blood pressure control for elderly patients; kangaroo care for low-birth-weight infants; footwear for knee osteoarthritis; and delayed antibiotics for pediatric respiratory infections. Two "honourable mention" studies are also briefly reviewed. CONCLUSION: Research from 2021 produced several high-quality studies in cardiovascular care but also addressed a variety of conditions relevant to primary care including weight loss, depression, and COVID-19.
OBJECTIVE: To summarize 10 high-quality studies or guidelines from 2021 that have strong relevance to physicians in comprehensive family practice. SELECTING THE EVIDENCE: Routine literature surveillance of abstracts in high-impact journals and EvidenceAlerts was completed by the PEER (Patients, Experience, Evidence, Research) team, a group of health care professionals with a research interest in evidence-based medicine and primary care. Abstracts were screened, selected, and ranked by the PEER team. MAIN MESSAGE: The articles from 2021 that are most likely to impact primary care practice discuss the following topics: empagliflozin for heart failure with preserved ejection fraction; semaglutide for weight loss; stopping antidepressants in primary care; inhaled budesonide for COVID-19; acetylsalicylic acid for preeclampsia prevention; quarter-dose blood pressure medications for hypertension; aggressive blood pressure control for elderly patients; kangaroo care for low-birth-weight infants; footwear for knee osteoarthritis; and delayed antibiotics for pediatric respiratory infections. Two "honourable mention" studies are also briefly reviewed. CONCLUSION: Research from 2021 produced several high-quality studies in cardiovascular care but also addressed a variety of conditions relevant to primary care including weight loss, depression, and COVID-19.
Authors: Robin Carhart-Harris; Bruna Giribaldi; Rosalind Watts; Michelle Baker-Jones; Ashleigh Murphy-Beiner; Roberta Murphy; Jonny Martell; Allan Blemings; David Erritzoe; David J Nutt Journal: N Engl J Med Date: 2021-04-15 Impact factor: 91.245
Authors: Kade L Paterson; Kim L Bennell; Penny K Campbell; Ben R Metcalf; Tim V Wrigley; Jessica Kasza; Rana S Hinman Journal: Ann Intern Med Date: 2021-01-12 Impact factor: 25.391
Authors: Kim Chi Luong; Tien Long Nguyen; Duy Huong Huynh Thi; Henri P O Carrara; Nils J Bergman Journal: Acta Paediatr Date: 2015-10-15 Impact factor: 2.299
Authors: Gemma Lewis; Louise Marston; Larisa Duffy; Nick Freemantle; Simon Gilbody; Rachael Hunter; Tony Kendrick; David Kessler; Dee Mangin; Michael King; Paul Lanham; Michael Moore; Irwin Nazareth; Nicola Wiles; Faye Bacon; Molly Bird; Sally Brabyn; Alison Burns; Caroline S Clarke; Anna Hunt; Jodi Pervin; Glyn Lewis Journal: N Engl J Med Date: 2021-09-30 Impact factor: 91.245
Authors: Sanjay Ramakrishnan; Dan V Nicolau; Beverly Langford; Mahdi Mahdi; Helen Jeffers; Christine Mwasuku; Karolina Krassowska; Robin Fox; Ian Binnian; Victoria Glover; Stephen Bright; Christopher Butler; Jennifer L Cane; Andreas Halner; Philippa C Matthews; Louise E Donnelly; Jodie L Simpson; Jonathan R Baker; Nabil T Fadai; Stefan Peterson; Thomas Bengtsson; Peter J Barnes; Richard E K Russell; Mona Bafadhel Journal: Lancet Respir Med Date: 2021-04-09 Impact factor: 30.700
Authors: Ly-Mee Yu; Mona Bafadhel; Jienchi Dorward; Gail Hayward; Benjamin R Saville; Oghenekome Gbinigie; Oliver Van Hecke; Emma Ogburn; Philip H Evans; Nicholas P B Thomas; Mahendra G Patel; Duncan Richards; Nicholas Berry; Michelle A Detry; Christina Saunders; Mark Fitzgerald; Victoria Harris; Milensu Shanyinde; Simon de Lusignan; Monique I Andersson; Peter J Barnes; Richard E K Russell; Dan V Nicolau; Sanjay Ramakrishnan; F D Richard Hobbs; Christopher C Butler Journal: Lancet Date: 2021-08-10 Impact factor: 79.321